Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV - Post by User

Avivagen Inc > supplements for humans set to debut in the U.S. next week
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(208)
•••
Post by StoneMan45on Jan 30, 2021 10:24am
128 Views
Post# 32427984

supplements for humans set to debut in the U.S. next week

supplements for humans set to debut in the U.S. next week

Ottawa bioscience firm Avivagen set to unveil immune-boosting supplements for humans



url=https://obj.ca/article/techopia/ottawa-bioscience-firm-avivagen-set-unveil-immune-boosting-supplements-humans?fbclid=IwAR1ON6rXdTO0z5VQQkqEydVJsLoIFuoIfYd3IrSql3xVLuLyKI760fy4Rk8][/url]


 
Avivagen Inc.
Yesterday at 10:15 AM 
 
With the new product set to debut on Amazon in the U.S. next week, CEO Kym Anthony believes Avivagen – fortified by millions of dollars in new financing – is about to have its day in the sun
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities